Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26

Core Insights - MDxHealth SA will release its financial results for the fourth quarter and full year ended December 31, 2025, on February 26, 2026, after market close [1] - A conference call with live Q&A will be hosted on the same day at 4:30 PM ET / 22:30 CET [2] Company Overview - MDxHealth is a leading precision diagnostics company that provides actionable molecular information to personalize patient diagnosis and treatment [3] - The company's tests utilize proprietary genomic, epigenetic, exosomal, and other molecular technologies to assist in the diagnosis and prognosis of urologic cancers and diseases [3] - The U.S. headquarters and laboratory operations are located in Irvine, California, with additional labs in Waltham, Massachusetts, and Plano, Texas, while the European headquarters is in Herstal, Belgium [3]